Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Cancer biomarkers relying on methylation could forecast tumor type

In cancer management, biomarkers are commonly used to guide treatment decisions and evaluate patient outcomes.

23 May 2022

Research may lead to new therapies for metabolic disorders and other diseases

Researchers at UT Southwestern have uncovered a molecular path that allows cells to detect when their lipid supplies are running low, triggering a flurry of activity that avoids starvation.

23 May 2022

New chemical technique with CRISPR gene-editing tool helps to cure genetic diseases

CRISPR, a gene-editing technique that allows scientists to mend the DNA of human cells almost as easily as using a pair of scissors, has boosted biological and medical research in the last decade.

23 May 2022

Researchers create open-access atlases of human immune cells in adults

Previously unknown immune cell types throughout development and adulthood have been identified, providing new insights into how the human immune system functions.

18 May 2022

Research sheds light on mechanism for skin cell death, likely to help treat cancer

Researchers at Emory University have uncovered a mechanism for skin cell death that might lead to novel therapies for “flesh-eating” infections, alopecia, hives, and possibly even melanoma, the deadliest type of skin cancer.

18 May 2022

Research shows how visible hotspots may be easy to target with immune-stimulating drugs

Many cancers include genetic “hotspots,” or sections of DNA that are subject to mutation. For example, a mutation in the TP53 gene is found in more than 50% of all cancers, generally within a narrow DNA range.

18 May 2022

Scientist reveals the impact of mitochondria in metastatic prostate cancer

Prostate cancer that has spread to other regions of the body is commonly treated with hormone treatment, but many individuals develop resistance to it, making their disease more aggressive and potentially fatal.

12 May 2022

New technique uses genetic data that may better predict disease risk in a population

Polygenic risk scores (PRS) are promising tools for forecasting disease risk, but current versions have bias built-in, which can reduce their accuracy in some populations and lead to health disparities.

10 May 2022

Study shows new potential target for CAR T cells to inhibit solid tumors

CAR T therapy, or chimeric antigen receptor T-cell therapy, has revolutionized the treatment of some blood cancers, allowing patients with relapsed or refractory disease to live longer and better lives.

10 May 2022

Study reveals advance in cell biology may lead to effective cancer therapy technique

According to researchers at Weill Cornell Medicine and the Dana-Farber Cancer Institute, a protein called CDC7, which has long been assumed to play an important role in cell division, may be replaced by another protein called CDK1.

10 May 2022

Study shows how key cause of cancer growth in cell formation may lead to prevention

The University of Warwick’s research gives fresh information on a major cause of cancer growth during cell division (or mitosis), as well as potential treatments for avoiding it.

From The University of Warwick 10 May 2022

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Combining Alamar's Attobody™ platform with Mologic's RDTs, this collaboration focuses on developing highly sensitive COVID-19 tests for global health readiness.

5 May 2022

New sensor to detect early-stage lymphedema could spare thousands of patients a year

A sensor created by Johns Hopkins University graduate students to detect very early-stage lymphedema could spare thousands of patients a year, many women with breast cancer, from the painful, debilitating condition.

3 May 2022

Gene expression signatures in lymph node cells play an active role in lymphoma development

Researchers from the University of Tsukuba identify gene expression signatures in different types of lymph nodes cells that play an active role in the development of lymphomas.

3 May 2022

Researchers discover protein that enhances muscle mass

Humans are not just pumping iron in the gym, or not just oxygenating muscle cells, which keeps those muscles healthy, powerful, and developing—a process known as hypertrophy—that is defined as an increase in muscle mass, caused by an increase in muscle cell size.

29 Apr 2022

Researchers analyze the potential role of mRNA in drug development and novel therapies

In latest years, messenger RNA—the DNA’s close relative in the complex process of turning a string of genetic blueprints into a properly functioning organism—has gotten a lot of attention in the scientific and medical community.

29 Apr 2022

Study explains how liver regeneration may help treat liver disease in mice

Other vertebrates, such as fish and lizards, can regenerate organs more effectively than mammals. Salk researchers have discovered a mechanism to partially restore the young condition of liver cells, allowing them to repair damaged tissue at a quicker rate than previously thought.

29 Apr 2022

Study shows the role of mucosal-associated invariant T cell in mucosal melanomas patients

Many cancer patients have benefited from the development of anti-cancer immunotherapy drugs known as immune checkpoint inhibitors, but patients with mucosal melanomas—melanomas that occur in the mucous membranes of the head, neck, eyes, respiratory system, and genitourinary region rather than on the skin—are highly resistive to immune checkpoint inhibitors for reasons researchers do not fully understand.

29 Apr 2022

Researchers shed light on development and treatment of brain diseases

It is highly regulated what goes into the brain and what does not. The phagocytes that encapsulate the blood arteries in the brain and maintain the blood-brain barrier have been examined by researchers at the University of Freiburg’s Faculty of Medicine.

25 Apr 2022

Researchers discover a unique origin of severe pediatric brain cancer

A new cause of severe childhood brain cancer has been discovered by scientists.

25 Apr 2022

Cancer News and Research

Cancer biomarkers relying on methylation could forecast tumor type

Research may lead to new therapies for metabolic disorders and other diseases

New chemical technique with CRISPR gene-editing tool helps to cure genetic diseases

Researchers create open-access atlases of human immune cells in adults

Research sheds light on mechanism for skin cell death, likely to help treat cancer

Research shows how visible hotspots may be easy to target with immune-stimulating drugs

Scientist reveals the impact of mitochondria in metastatic prostate cancer

New technique uses genetic data that may better predict disease risk in a population

Study shows new potential target for CAR T cells to inhibit solid tumors

Study reveals advance in cell biology may lead to effective cancer therapy technique

Study shows how key cause of cancer growth in cell formation may lead to prevention

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

New sensor to detect early-stage lymphedema could spare thousands of patients a year

Gene expression signatures in lymph node cells play an active role in lymphoma development

Researchers discover protein that enhances muscle mass

Researchers analyze the potential role of mRNA in drug development and novel therapies

Study explains how liver regeneration may help treat liver disease in mice

Study shows the role of mucosal-associated invariant T cell in mucosal melanomas patients

Researchers shed light on development and treatment of brain diseases

Researchers discover a unique origin of severe pediatric brain cancer

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics